Nanodevices for the prevention and treatment of cardiovascular diseases

作者：Manuel Velez Resendiz Juan; Jesus Velez Arvizu Juan

来源：Gaceta Medica de Mexico, 2018, 154(3): 358-367.

DOI：10.24875/GMM.18002507

• Nanomedicine
• Nanocarriers
• Nanodevices
• Nanotechnology
• Drug delivery systems
• Cardiovascular diseases
• Smart drugs

Currently, cardiovascular disease represents the main cause of morbidity and mortality worldwide; the application of nanotechnology holds great promise for its prevention and treatment. Nanodevices ("smart drugs") are currently being developed for directed and controlled delivery of drugs to specific sites in the body, such as cells, tissues, blood vessels and the heart, as well as for diagnosis and early detection of cardiovascular conditions and patient-individualized treatment. Another application of nanodevices is the delivery of drugs to correct defective protein bad coupling or binding. With potent super-effects, nanoparticles should be able to elicit therapeutic effects at lower doses and prolonged periods. The manufacture of nanodevices and nanocarriers should be with a comprehensive approach that takes general properties into account in order to assess for biocompatibility and, therefore, avoid adverse and toxic effects. Intensified research in this field will help to significantly reduce morbidity and mortality caused by cardiovascular disease.

• 出版日期2018-6